Optimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting?

INTRODUCTION: There are currently two recommended radiation strategies for clinical stage III NSCLC: a lower “preoperative” (45–54 Gy) and a higher “definitive/nonsurgical” (60–70 Gy) dose. We sought to determine if definitive radiation doses should be used in the preoperative setting given that man...

Descripción completa

Detalles Bibliográficos
Autores principales: Saffarzadeh, Areo G., Canavan, Maureen, Resio, Benjamin J., Walters, Samantha L., Flores, Kaitlin M., Decker, Roy H., Boffa, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474436/
https://www.ncbi.nlm.nih.gov/pubmed/34590044
http://dx.doi.org/10.1016/j.jtocrr.2021.100201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474436/
https://www.ncbi.nlm.nih.gov/pubmed/34590044
http://dx.doi.org/10.1016/j.jtocrr.2021.100201

Ejemplares similares